Abstract Beta-amyloid (β-A) peptides are potential biomarkers to monitor Alzheimer's diseases (AD) for diagnostic purposes. Increased β-A level is neurotoxic and induces …
H Wang, X Mu, J Yang, Y Liang, XD Zhang… - Coordination Chemistry …, 2019 - Elsevier
As the centralized control system of the body, the brain is a complex organ of the utmost importance that even the most minor disorder and trauma can cause inestimable harm …
K Lv, H Wang, X Fu, S Chen, R Zhang, Y Zhou, J Feng… - Small, 2024 - Wiley Online Library
Although research on photodynamic therapy (PDT) of malignant tumor has made considerable progress in recent years, it is a remaining challenge to extend PDT to the …
X Wang, X Gu, L Li, B Yu, L Lv, Q Chen… - Analytical and Bioanalytical …, 2021 - Springer
An excellent aptasensor for electrochemical detection of amyloid-β oligomers (AβOs) at trace levels was fabricated based on a triple-helix aptamer switch (THAS) via target …
M JIANG, W Xiao-Ying, W Xiao-Bing - Chinese Journal of Analytical …, 2018 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disease with unknown etiology. β-amyloid protein (Aβ) is one of the specific biomarkers of AD, and many clinical studies suggest that …
Q Liu, Y Men, D Fang, Y Miao, D Ye… - Chemistry–A European … - Wiley Online Library
The fluorescent imaging of pathologically accumulated β‐amyloid (Aβ) proteins is of significant importance to the diagnosis of Alzheimer's disease (AD). In the paper, we …
Abnormal protein aggregation has been commonly observed in a variety of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD) …
AD was described a century ago with a pathological lesion of amyloid plaques accumulated in the brain. Amyloid plaques of Aβ and neurofibrillary tangles (NFTs) of tau are the two …